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use self-reporting, proxy reporting, or both20). Clinicians often 
rely on parents for guidance regarding their child’s health-relat-
ed quality of life (HRQOL) as they play an important role in 
medical decision making8). Even when a child’s responses are 
available, the perspective of parent has an important bearing a 
health care decision with respect to the child8). Although par-
ents don’t always concur on all aspects of the child’s HRQOL, 
they are more reliable than other proxies such as teachers and 
health professionals21). For these reasons, parallel reporting is 
increasingly recommended in studies involving the assessment 
of health outcomes in child populations with analogous ques-
tionnaires for children and their parents being developed8).
In case of child brain tumor (BT) patients, many health out-
come studies in pediatric psycho-oncology have excluded child 
BT patients from study participation, as their experiences were 
INTRODUCTION
Parents are recognized as one of the main sources of emo-
tional support for children with cancer15). Many children with 
cancer currently receive a large proportion of their treatment at 
home, placing an added burden of care on family members9). 
Unlike adult measures of quality of life (QOL) in the patients, 
which rely on self-reporting, measures of QOL in children may 
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ateness), and ease of administration is needed particularly in busy 
clinical settings, when selecting a HRQOL instrument for a study, 
and the pedsFACT-BrS has the advantage of these criterions. 
Until now, we had finished the validation studies of the brain 
tumor-specific tool for measurement of childhood BT survi-
vors’ QOL, the patient’s version of both the pediatric functional 
assessment of cancer therapy questionnaire (version 2.0) in 
brain tumor survivors aged 7-1226), and aged 13 years and old-
er25), and then we found that these tools could be reliable and 
valid instruments. 
The value of proxy reporting is still controversial19). Before we 
started the validation study of pedsFACT-BrS parent form, we 
investigated the agreement between self-report from pediatric 
brain tumor patients and proxy reports from their parents wheth-
er it would be necessary to perform the validation study of both 
pedsFACT-BrS age 7-12 and aged 13 years and older(parent 
form) or not26). According to the result of Yoo et al.26), the prop-
er use of the pedsFACT-BrS for their parent proxies had pro-
vided clinicians with valid information about the overall QOL 
of child and adolescent BT patients, including their general 
health and their brain tumor specific well-being, so we have 
performed the validation study of pedsFACT-BrS aged 7-12 
and aged 13 and older parent proxy version individually. This 
study was at first to evaluate the reliability and validity of the 
Pediatric Functional Assessment of Cancer Therapy Question-
naire Brain Tumor Survivor (version 2.0) Aged 13 years and old-
er (Parent Form) (pedsFACT-BrS parent of adolescent) before 




We enrolled 170 adolescent brain tumor patients’ mothers 
(Table 1). The patients were recruited from Asan medical center 
(n=72), Severance children’s hospital (n=62), Seoul National 
university hospital (n=24), and National cancer center (n=12). 
All mothers with patients returning for routine follow-up ap-
pointments were consecutively asked to enroll between Decem-
ber 2006 and December 2009. Parents were excluded if they had 
pre-existing cognitive impairment, psychiatric disorders, or 
hearing loss. Informed consent was obtained from all partici-
pants. As previous childhood studies contained only small num-
bers of cases, we decided to perform a multicenter study. As was 
in Yoo et al.’s25) result, the patients’ frequencies of tumor patho-
logic subtypes in this study were similar to those reported for 
the American population1,7) and for earlier Korean popula-
tions10), except that the proportion of germ cell tumor patients 
(27.1%) was particularly high in our sample. We considered the 
incidence in the East was between 2.1-9.4%, which seemed no-
ticeably higher than in the West, and in particular, the incidence 
of Korea and Japan was much higher than that of other eastern 
countries3).
considered atypical to that of the majority of pediatric survi-
vors1,11,18), and because none were designed specifically for survi-
vors of childhood brain tumors11). In 2007, Palmer and co-work-
ers17) presented the 24-item PedsQLTM BT module, and Lai and 
colleagues11) also developed the 34-item Patient and Parent Ver-
sion (ages 7-12 years; grade school) of the Pediatric Functional 
Assessment of Cancer Therapy-BT Survivor (pedsFACT-BrS) 
for assessing HRQOL of child BT patients, and has been extend-
ed to adolescent for both patient and parent since then. 
Tao and Parsons22) suggested that brevity, instrument practicali-
ty (e.g., length of questionnaire; language suitability; age-appropri-
Table 1. Demographic and clinical characteristics of 170 adolescent 
brain tumor patients and their parent
Variables Mean (SD, %)
Parents of adolescent brain tumor patients
    Mean age of parent 43.98 (3.54)
    Mean age of education 12.97 (2.08)
Marital status
    Married    168 (98.8)
    Divorced         2 (1.2)
Occupation status
    Homemaker    165 (97.1)
    Full time         3 (1.8)
    Part time         2 (1.1)
Adolescent brain tumor patients
Sex
    Male       99 (58.2)
    Female       71 (41.8)
Mean age (SD) 15.34 (2.26)
Mean age of education (SD) 13.14 (2.32)
Pathology
    Medulloblastoma/PNET       25 (14.7)
    Malignant glioma       22 (12.9)
    Low-grade glioma       33 (19.4)
    Other low grade neoplasm       44 (25.9)
    Germ cell tumor       46 (27.1)
Treatment received
    Surgery only       73 (42.91)
    Surgery+chemotherapy+radiotherapy       48 (28.2)
    Surgery+radiotherapy       49 (28.8)
Location
    Supratentorial     111 (65.3)
    Infratentorial       59 (34.7)
Shunt
    Yes       33 (19.4)
    No     137 (80.6)
Currently receiving treatment
    Yes       38 (22.4)
    No     132 (77.6)
PWD : physical well-being, SFWB : socal/family well-being, EWB : emotional well-
being and illness experience, BTS : brain tumor survivor-specific concerns, PSF : 
psychosocial function (SFWB+EWB), pedsFACT-Brs : pedsFACT-Brs total score
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item, and each of the scales were summed. The Cronbach’s al-
pha coefficients were 0.71 for P, 0.82 for E-I, 0.85 for N, and 
0.80 for L. In this study, we analyzed only the N score.
Child health questionnaire-Parent version12,23) 
The CHQ, a multidimensional generic health-related quality of 
life instrument, was constructed to measure the physical and psy-
chosocial well-being of children 5 years of age and older12). The 
CHQ-PF 50 is completed by the parent as proxy for the child12,23). 
This questionnaire provides thirteen separate scale scores : physi-
cal functioning (PF), role/social limitations-physical (RP), gener-
al health perception (GH), bodily pain (BP), family activities 
(FA), role/social limitation/emotional/behavioral (REB), time 
impact on parent (PT), emotional impact on parent (PE), self-es-
teem (SE), mental health (MH), behavior (BE), family cohesion 
(FC), and change in health (CH). We analyzed only the PF 
(α=0.78), MH (α=0.82), SE (α=0.74) in this study. 
N, MH, and SE scores were used as measures of related con-
cept (emotion). And PF was used as related concept (physical 
function), too. It was expected that correlations with N, MH, 
and SE should be stronger for EWB answers, moderate to low 
for PWB and BTS answers, because these are measures of emo-
tion. And correlation with PF was expected to be stronger for 
PWB answers, moderate to low for SFWB and BTS, because PF 
is measure of physical function. According to Dawson et al.5) a 
coefficient correlation value of 0.60-0.79 indicated a strong cor-
relation and 0.40-0.59 a moderate correlation. 
Procedures
The pedsFACT-BrS parent of adolescent questionnaire was 
administered verbally by research nurses to ensure that ques-
tions were always posed in the same manner. A research assis-
tant was available to answer questions raised by participants 
during completion of the self-administered instruments at the 
outpatient clinic. 
Statistical analyses
Descriptive statistics [means, standard deviation (SD), and 
frequencies] were calculated for all variables, and group differ-
ences were assessed using analysis of covariance, controlling 
statistics for mother age, and mother’s educational age. Internal 
consistency reliability was assessed using Cronbach’s alpha. The 
intraclass correlation coefficient (ICC) (Two-way random effect 
model absolute agreement definition) was used to assess instru-
ment’s test-retest reliability. Pearson product moment correla-
tion was used to determine the convergent and divergent validi-
ties of pedsFACT-BrS parent of adolescent, including assessment 
of the overall scale, subscales. We classified patients into three 
groups based on Karnofsky score assessed by patient’s mother; 
Karnofsky score of 100, 90, or 80.
The independent sample t-test and one-way ANOVA were 
employed to determine whether the test was able to discriminate 
across Karnofsky score assessed by patient’s mother, shunt, tu-
Assessment tool
pedsFACT-BrS parent of adolescent 
The pedsFACT-BrS adolescents consisted of 37 items: 25 ge-
neric concerns [7 on physical well-being (PWB), 13 on emo-
tional well-being and illness experiences (EWB), 5 on social/
family well-being (SFWB)], and 12 brain tumor survivor-spe-
cific concerns (the BTS questions)11) ( http://www.facit.org).  
Development of the Korean pedsFACT-BrS parent of 
adolescent
The pedsFACT-BrS parent of adolescent was translated em-
ploying standard FACIT methodology2). A provisional version 
of the instrument was pre-tested on 30 mothers in total, 5 moth-
ers each according to their children’s age between 13 to 18 years 
during their follow-up clinic visits. Participants were asked to 
self-administer the questionnaires. Subjects were asked to write 
their opinions on the questions below that had made to clarify 
what and how many items made subjects discomfort. 
1) Would you please tell me which items were difficult to un-
derstand and why they were difficult? Also, could you suggest a 
better way to phrase these items?
2) Would you please tell me which items were not relevant or 
were offensive, and why? Also, could you suggest a better way 
to phrase these items?
3) Is there anything else that should have been included relat-
ed to your children’s condition? Would you please tell me what 
should be added?
Reliability
Internal consistency coefficients were calculated for each sub-
scale. We performed test-retests at intervals of 7-10 days in 30 
mothers among the 170 subjects who agreed to complete the 
questionnaire twice. 
Clinical validity
We determined discrimination of the pedsFACT-BrS parent 
of adolescent by comparing the pedsFACT-BrS parent of ado-
lescent scores to Karnofsky scores, pathology, treatment type, 
tumor location, shunt, and treatment on/off status.
Convergent and divergent validity
Convergent and divergent validity were assessed by compar-
ing patient responses with those on the neuroticism in EPQ6,13) 
and mental health (MH), self-esteem (SE), physical functioning 
(PF) in Child health questionnaire12,23). 
Eysenck Personality Questionnaire6,13) 
We used the Korean version13) of the short form of the EPQ6) 
(KEPQ). The KEPQ-short form is composed of a total of 48 
items, consisting of four scales [psychoticism (P), extraversion-
introversion (E-I), neuroticism (N), and lying (L)] with 12 items 
each. Respondents were asked to check “yes” or “no” for each 
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strongly correlated with PF scores (convergent validity), where-
as SFWB and BTS were associated to a lesser degree with such 
assessments (divergent validity). Correlations greater than 0.40 
have been considered to be satisfactory convergent validity. 
Conversely, for adequate divergent validity, scales measuring 
different constructs should show low correlations, well under 
0.40.27) Correlations between EWB and N (r=-0.72), between 
EWB and MH (r=0.60), and between EWB and SE (r=0.62) were 
stronger that we had expected, reflecting measurement of the 
same phenomenon. In contrast, correlations between SFWB and 
MH (r=0.32), between BTS and MH (r=0.14), between BTS 
and SE (r=0.29) were low, indicating that different phenomena 
were being addressed. Correlations between PWB and PF (r=-
0.78) was stronger than we had predicted, reflecting measure-
ment of the same phenomenon. In contrast, correlations between 
BTS and PF (r=0.26) was low, indicating that different phenom-
enon was being addressed (Table 3).
 Known group comparison
Overall questionnaire data (p<0.001) and subscale results 
(p<0.001) enabled discrimination by Karnofsky score. Analysis 
by treatment type revealed significant differences in PWB 
(p<0.001), SFWB (p<0.01), EWB (p<0.05), PSF (p<0.05), and 
overall scores (p<0.05) except BTS. Significant differences be-
tween tumor location (supratentorial vs. infratentorial) and be-
tween shunt-yes and shunt-no were seen in PWB (p<0.001), 
EWB (p< 0.05), PSF (p<0.05), and overall scores (p<0.05). Final-
ly, significant differences between treatment-on and treatment-
off status were also seen in PWB (p<0.001), SFWB (p<0.05), 
EWB (p<0.01), BTS (p<0.05), PSF (p<0.01), overall scores 
(p<0.001) (Table 4). 
DISCUSSION
The results presented here show the 
good psychometric properties of the 
Korean version of the pedsFACT-BrS 
parent of adolescent, including internal 
consistency, test-retest reliability, good 
convergent and divergent validity, and 
known group validity. As expected, the 
correlations among EWB, N, MH, and 
SE subscales showed that essentially the 
same phenomenon (emotion) was be-
ing measured. N, MH, SE scores were 
correlated well with EWB scores (con-
vergent validity) and poorly with 
SFWB and BTS (divergent validity). 
The correlations between PWB and PF 
subscales showed that essentially the 
same phenomenon (physical function) 
was being measured. PF score was cor-
related well with PWB scores (conver-
mor location, type of treatment, and receiving-treatment status. 
Statistical analysis was conducted using standard SPSS Statistical 
Analysis System Version 16.0 software (SPSS Inc, Chicago, IL). 
RESULTS
Pre-testing
All 30 mothers had reported that there were no difficult, irrele-
vant, or offensive items in pedsFACT-BrS parent of adolescent re-
ported. And, they had no item that had been included related to 
their conditions. Cronbach’s α coefficient showed acceptable inter-
nal consistency (0.7)4), suggesting that translated items performed 
were well in association with other items in the same subscale. 
Reliability 
All Cronbach’s α coefficients were ranging from 0.76 to 0.94 
that exceeded Nunally’s criterion16) of 0.7 for modest reliability. 
The assessment of test-retest reliability using ICC revealed satis-
factory values with ICCs ranging from 0.84 to 0.93 (Table 2). 
An ICC value of 0.7 or greater was considered to indicate ac-
ceptable reliability4,14).   
Validity 
None of age, age of education showed significant associations 
with total QOL. Pathological diagnosis was not significantly as-
sociated with total QOL. 
Convergent and divergent validity 
We hypothesized that the EWB was strongly correlated with 
MH and SE scores (convergent validity), whereas SFWB and 
BTS were associated to a lesser degree with such assessments 
(divergent validity). It was hypothesized that the PWB was 
Table 2. Means, standard deviations, internal consistencies, and test-retest reliabilities
Mean (SD)  Cronbach’s α  
Test-retest reliability 
(ICC, 95% CI)
PWB (7 questions) 20.99 (6.14) 0.86          0.84 (0.71-0.92)
SFWB (5 questions) 12.43 (3.81) 0.76 0.89 (0.78-0.94)
EWB (13 questions) 28.73 (7.21) 0.85 0.85 (0.70-0.93)
BTS (12 questions) 35.63 (9.45) 0.86 0.89 (0.78-0.95)
PSF (18 question)   42.12 (21.96) 0.89 0.91 (0.80-0.95)
Peds FACT-BrS (37 questions) 98.70 (9.91) 0.94 0.94 (0.88-0.97)
BTS : brain tumor survivor-specific concerns, EWB : emotional well-being and illness experiences, PWB : physi-
cal well-being, SFWB : social/family well-being, pedsFACT-BrS : pedsFACT-BrS total score, PSF : psychosocial 
function (SFWB+EWB)
Table 3. Correlations of pedsFACT-BrS answers with N, PF, MH, SE, and GH
variables SFWB EWB BTS Peds-FACT-BrS N PF MH SE
PWB 0.50 0.51 0.51 0.76 -0.52 0.78 0.30 0.51
SFWB 1 0.49 0.58 0.82 -0.46 0.45 0.32 0.50
EWB 1 0.53 0.81 -0.72 0.42 0.60 0.62
BTS 1 0.88 0.48 0.26 0.14 0.29
Peds-FACT-BrS 1 -0.71 0.56 0.34 0.58
PF : physical functioning, MH : mental health, SE : self-esteem, N : neuroticism
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Our results were partially similar to those of Bhat and col-
leagues1) study, because parents in their study reported that pa-
tients who had a shunt also indicated lower physical (p<0.05) 
and psychosocial functioning (p<0.01).
But, in Bhat et al.1) study, parents reported that patients who 
had a shunt indicated decreased social functioning (p<0.05), 
which was different from our result. In tumor location, Bhat et 
al’s1) study didn’t show the significant difference between supra-
tentorial group and infratentorial group either in self-reports or 
parent proxy reports, and that children with infratentorial tu-
mor had significantly more problems communicating issues re-
lated to their illness than children with supratentorial tumors.1)
The difference between Bhat et al.1) and our study was proba-
bly due to the difference of brain tumor patients’ mean age lev-
el. Bhat et al’s1) patient mean age was 11.82 (SD=5.39) (child 
group), whereas the mean age of the patients in this study was 
15.37 (SD=2.23) (adolescent group). These differences indicat-
ed that children and adolescent might have different concerns 
with respect to their HRQOL25). 
The limitation of the present study is exclusion of fathers in the 
parent group. Although Russell et al.20) also revealed that no sig-
nificant difference in QOL outcomes when maternal and pater-
nal influences were considered9), we tried to enroll fathers in this 
study at the start, but we concluded that caregivers of adolescent 
BT patients in Korea were mostly their mothers, not their fathers.
gent validity) and poorly with BTS (divergent validity). 
Known group validities were confirmed by Karnofsky score, 
type of treatment, tumor location, presence of shunt, and receiv-
ing-treatment status. The parent report in this study indicated 
that the surgery-only group showed the highest scores in all sub-
scales and on overall pedsFACT-BrS parent of adolescent mean 
score except BTS, however there was no significant difference be-
tween surgery+radiotherapy group and surgery+radiotherapy+ 
chemotherapy group . 
We could not compare our results directly with any previous 
report because no studies on the QOL of adolescent-only BT 
patients have been conducted except our adolescent patient 
group’s report25). Our results were very similar to those of ado-
lescent BT patients25) except SFWB. And, though our results 
were similar to those of Bhat and colleagues1), we did not have a 
no-treatment group or a radiotherapy-only group in our study. 
Therefore, further research is needed to compare the QOL of 
BT patients according to their treatment type such as surgery-
only, radiation-only, or other treatments.
In this study, tumor location and presence of shunt affected 
PWB, EWB, PSF, overall scores except SFWB, and BTS. Moth-
ers with patients with infratentorial tumor or presence of shunt 
indicated that their children indicated lower physical function, 
psychosocial function, and overall HRQOL than mothers with 
patients with supratentorial or non-presence of tumor group. 
Table 4. Differences in pedsFACT-BrS scores according to Karnofsky scores, treatment type, location, shunt, and treatment on/off status
Variables   N PWB SFWB EWB BTS PSF PedsFACT-BrS
Karnofsky
    100   63 25.13 (3.09) 14.53 (2.42) 28.04 (6.61) 41.68 42.57 (7.51) 109.38 (14.71)
    90   58 21.18 (4.26) 12.85 (3.08) 25.23 (5.87) 33.93 38.09 (8.10) 92.07 (17.53)
    80   48 15.02 (6.61) 10.78 (3.62) 21.12 (7.06) 33.17 31.90 (9.64) 80.85 (19.63)
    F-value 48.93*** 16.52*** 12.42*** 16.01*** 17.68*** 30.61*** 
(1>2>3) (1>2>3) (1>2,3) (1>2,3) (1>2>3) (1>2>3)
Treatment type
    Surgery   73 23.49 (4.37) 13.42 (3.23) 26.17 (6.34) 36.12 (9.14) 57.85 (11.98) 99.21 (19.28)
    S+R   48 18.91 (6.15) 11.75 (4.13) 23.80 (7.34) 36.12 (8.72) 52.11 (14.29) 90.58 (20.32)
    S+R+C   49 19.58 (7.10) 11.73 (3.76) 23.76 (7.81)   34.29 (10.75) 51.49 (45.82) 88.86 (25.62)
    F-value 13.43*** 4.68** 2.82* 0.56 4.34* 4.42* 
(1>2,3) (1>2,3) (1>2,3) (1,2,3) (1>2,3) (1>2,3)
Location
    Supratentorial 111 18.96 (4.67) 12.71 (3.99) 25.64 (6.79) 35.99 (9.46) 38.36 (9.51) 96.59 (21.49)
    Infratentorial   59 15.45 (6.32) 11.86 (3.46) 23.10 (7.67) 34.71 (9.49) 34.97 (10.36) 88.13 (22.09)
    T-value 4.26*** 1.45 2.31* 0.87 2.23* 2.52*
Shunt
    Yes   33 18.45 (6.73) 11.86 (3.46) 23.11 (7.67) 34.71 (9.49)   34.97 (10.36) 88.14 (22.10)
    No 137 22.37 (5.35) 12.71 (3.99) 25.64 (6.79) 35.99 (9.46) 38.36 (9.51) 96.60 (21.49)
    T-value 4.04*** 1.50 2.23* 0.84 2.18* 2.50*
Treatment
    On   38 18.24 (6.27) 11.71 (2.88) 22.96 (5.79) 33.27 (8.24) 50.76 (10.38) 86.18 (16.37)
    Off 132 22.38 (5.47) 12.80 (4.04) 25.69 (7.45) 36.76 (9.59) 56.16 (14.96) 97.52 (22.57)
    T-value -4.25*** -2.01* -2.65** -2.48* -2.79** -3.79***
*p<0.05, **p<0.01, ***p<0.001. S+R : surgery+radiotherapy, S+R+C : surgery+radiotherapy+chemotherapy 
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the Pediatric Functional Assessment of Cancer Therapy Questionnaire 
(version 2.0) in brain tumor survivors aged 13 years and older. J Pain 
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atric functional assessment of cancer therapy : patient version 2 of 
“brain tumor survivor” for grade school patients aged 7-12 years. Qual 
Life Res : 2010 in press
CONCLUSION
The present results suggest that the Korean translation of the 
pedsFACT-BrS parent of adolescent is a reliable and valid in-
strument for measuring the QOL of Korean adolescent BT pa-
tients. Further research is needed not only to determine wheth-
er the questionnaire remains efficient and sensitive to detect 
longitudinal QOL changes in adolescent BT parent overall, but 
also whether it is suitable for detecting longitudinal QOL changes 
within homogeneous patient groups, such as those with medul-
loblastoma, or according to treatment type. It is also needed 
that the validation study of pedsFACT-BrS aged 7-12 parent 
form also has to be performed in near future. 
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